BACTERIAL ENDOCARDITIS WITH CANDIDA ALBICANS SUPERINFECTION

Insights

This study details two fatal cases of bacterial endocarditis complicated by Candida albicans superinfection. Antibiotic therapy may increase the risk of developing this serious fungal infection in at-risk patients.

Area of Science:

  • Medicine
  • Infectious Diseases
  • Cardiology

Background:

  • Candida endocarditis is an emerging disease entity with increasing incidence.
  • Patients with bacterial endocarditis are at increased risk for Candida superinfection.
  • Superinfections can significantly complicate the clinical course of endocarditis.

Purpose of the Study:

  • To describe the clinical and pathological features of two fatal cases of bacterial endocarditis with Candida albicans superinfection.
  • To highlight the potential role of antibiotic therapy in the development of fungal endocarditis.
  • To contribute to the understanding of this rare but serious complication.

Main Methods:

  • Case report of two patients with fatal endocarditis.
  • Identification of causative organisms (bacteria and Candida) through blood cultures and postmortem examination.
  • Clinical and pathological data review.

Main Results:

  • Case 1: Combined Streptococcus viridans and Candida endocarditis of the aortic valve.
  • Case 2: Staphylococcus aureus tricuspid valve endocarditis progressing to Candida endocarditis in an intravenous drug user.
  • Candida albicans identified as a superinfecting organism in both fatal cases.

Conclusions:

  • Candida endocarditis is a recognized complication, particularly in patients with pre-existing bacterial endocarditis.
  • Antibiotic therapy may be a contributing factor in the development of Candida superinfection.
  • Prompt recognition and management strategies are crucial for improving outcomes in patients at risk.